Skip to main content
VCbacked
Log inGet Started

Elevara Medicine

London, United Kingdom

Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.

$70.0M raised
Oct 2025
Series A
Biotechnology

Top Investors

Sofinnova PartnersForbion Capital PartnersMonograph CapitalWeatherden

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Elevara Medicine

How much funding has Elevara Medicine raised?
Elevara Medicine has raised $70.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Who are Elevara Medicine's investors?
Elevara Medicine's investors include Sofinnova Partners, Forbion Capital Partners, Monograph Capital, Weatherden.
Where is Elevara Medicine headquartered?
Elevara Medicine is headquartered in London, United Kingdom.
What does Elevara Medicine do?
Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.
What stage is Elevara Medicine at?
Elevara Medicine is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Elevara Medicine — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/elevara-medicine. Accessed June 17, 2026.
APA
VCBacked. (2025). Elevara Medicine — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/elevara-medicine
Wikipedia (cite web)
{{cite web |title=Elevara Medicine — Funding & Investors |url=https://www.vcbacked.co/company/elevara-medicine |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong